Medical device recalls Moderate risk

Philips Respironics recalls Trilogy 100, Trilogy 200, Trilogy O2, Trilogy 202, Trilogy EC, Garbin, Garbin Plus Trilogy 100, Trilogy 200, Garbin, Ga…

Recall date
January 18, 2016
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-1065-2016
FDA classification
Class II
Brand / firm
Philips Respironics
Sold / distributed
Nationwide Distribution including Puerto Rico and Internationally to the US Virgin Islands.

Why it was recalled

Software Issue

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Trilogy 100, Trilogy 200, Trilogy O2, Trilogy 202, Trilogy EC, Garbin, Garbin Plus Trilogy 100, Trilogy 200, Garbin, Garbin plus provides continuous or intermittent ventilatory support for the care of individuals who require mechanical ventilation.

Get recall alerts

Free email alert whenever Philips Respironics has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Philips Respironics